Market Overview:
The global bio-identical hormone replacement therapy market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of hormonal imbalance, rising awareness about the benefits of bio-identical hormone replacement therapy, and technological advancements in the field of bio-identical hormones. The global bio-identical hormone replacement therapy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into creams, injections, implanted pellets, patches, and gels. The creams segment is expected to account for a major share in terms of revenue in 2018 owing to their high popularity among consumers due to ease of use and better absorption as compared with other forms such as injections or implants. On the basis of application, men are expected to account for a larger share in terms revenue than women duringthe forecast period owingto higher prevalenceof hormonal imbalanceamong men as compared with women.However,.
Product Definition:
Bio-identical hormone replacement therapy is the use of hormones that are chemically identical to those produced by the body. These hormones are used to replace hormones that are no longer being produced by the body, such as estrogen and testosterone. The importance of bio-identical hormone replacement therapy is that it can help to restore balance in the body and improve symptoms related to hormonal imbalance.
Creams:
Creams are topical formulations that contain the active ingredient estradiol and progesterone. They are used as a form of hormonal therapy for women to regulate and balance feminine hormones in the body.
The global market for BIIR was valued at USD 6,787 million in 2017.
Injections:
Injections are the most common form of bio-identical hormone replacement therapy (BHRT). They are used to deliver hormones in the body. Hormone injections have become very popular among menopausal women and people suffering from hypogonadism. The main factor responsible for this shift is convenience - it saves time by eliminating daily dosage requirement and reduces risk due to adverse effects associated with oral hormone supplements.
Application Insights:
Men application segment held the largest share of over 70.0% in 2017. Rising awareness about men's health issues and increasing acceptance of bio-identical hormones for treating these disorders are some of the factors responsible for this large share. Bio-identical hormones have been found to be more effective than conventional hormone replacement therapy in men due to a better balance between estrogen and progesterone, which results in improved quality of sleep, less hot flashes & night sweats, reduced anxiety and depression symptoms as well as improved sexual function.
The women application segment is expected to grow at a lucrative rate during the forecast period owing to rising awareness about hormone imbalance conditions such asPremenstrual syndrome (PMS), perimenopause/menopause transition problems along with an increase in number of female patients seeking bio-identical hormone replacement therapy after childbirth or before going through menopause due to natural declinement or absence of ovarian function.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of bio-identical hormone replacement therapy (BHRT) providers and high awareness levels coupled with relatively higher healthcare expenditure in this region are some factors attributing to its largest share. In addition, an increase in the number of patients suffering from chronic conditions such as osteoporosis, obesity, and menopausal hot flashes is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income leading to an increase in consumerism which subsequently drives demand for various advanced medical treatments such as bio-identical hormones replacing therapies for women and menopausal symptoms treatment options other than HRTs that are not available locally thus driving their demand through importation or export across international borders.
Growth Factors:
- Increasing awareness about the benefits of bio-identical hormone replacement therapy (BHRT) is driving the market growth.
- Growing geriatric population is also a major factor that is contributing to the growth of this market as they are more prone to suffer from hormonal imbalances and other age-related health problems.
- Rising prevalence of chronic diseases such as obesity, diabetes, and heart diseases has increased the demand for BHRT treatments as these conditions can be effectively managed with BHRT therapies.
- increasing number of women who are opting for preventive measures to maintain their health in later years is also propelling the growth of this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bio-identical Hormone Replacement Therapy Market Research Report
By Type
Creams, Injections, Implanted Pellets, Patches, Gels
By Application
Men, Women
By Companies
RevitaLife, SottoPelle, JumpstartMD, BioTE Medical, Aesthetic Everything
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Bio-identical Hormone Replacement Therapy Market Report Segments:
The global Bio-identical Hormone Replacement Therapy market is segmented on the basis of:
Types
Creams, Injections, Implanted Pellets, Patches, Gels
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Men, Women
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- RevitaLife
- SottoPelle
- JumpstartMD
- BioTE Medical
- Aesthetic Everything
Highlights of The Bio-identical Hormone Replacement Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Creams
- Injections
- Implanted Pellets
- Patches
- Gels
- By Application:
- Men
- Women
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bio-identical Hormone Replacement Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bio-identical hormone replacement therapy (BHRT) is a treatment for conditions such as menopause, perimenopause, and postmenopausal syndrome that uses hormones that are identical to the ones produced by the body.
Some of the key players operating in the bio-identical hormone replacement therapy market are RevitaLife, SottoPelle, JumpstartMD, BioTE Medical, Aesthetic Everything.
The bio-identical hormone replacement therapy market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bio-identical Hormone Replacement Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bio-identical Hormone Replacement Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bio-identical Hormone Replacement Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bio-identical Hormone Replacement Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bio-identical Hormone Replacement Therapy Market Size & Forecast, 2020-2028
4.5.1 Bio-identical Hormone Replacement Therapy Market Size and Y-o-Y Growth
4.5.2 Bio-identical Hormone Replacement Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Creams
5.2.2 Injections
5.2.3 Implanted Pellets
5.2.4 Patches
5.2.5 Gels
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Men
6.2.2 Women
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bio-identical Hormone Replacement Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bio-identical Hormone Replacement Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Creams
9.6.2 Injections
9.6.3 Implanted Pellets
9.6.4 Patches
9.6.5 Gels
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Men
9.10.2 Women
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Creams
10.6.2 Injections
10.6.3 Implanted Pellets
10.6.4 Patches
10.6.5 Gels
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Men
10.10.2 Women
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Creams
11.6.2 Injections
11.6.3 Implanted Pellets
11.6.4 Patches
11.6.5 Gels
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Men
11.10.2 Women
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Creams
12.6.2 Injections
12.6.3 Implanted Pellets
12.6.4 Patches
12.6.5 Gels
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Men
12.10.2 Women
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Creams
13.6.2 Injections
13.6.3 Implanted Pellets
13.6.4 Patches
13.6.5 Gels
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Men
13.10.2 Women
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bio-identical Hormone Replacement Therapy Market: Competitive Dashboard
14.2 Global Bio-identical Hormone Replacement Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 RevitaLife
14.3.2 SottoPelle
14.3.3 JumpstartMD
14.3.4 BioTE Medical
14.3.5 Aesthetic Everything
